Manjusha J. Gaglani MD
Professor with Tenure, Pediatrics, Baylor College of Medicine, Temple, Texas,
Join to view full profile
2401 S 31st StMS-CK-300Temple, TX 76508
Phone+1 254-935-5047
Fax+1 254-935-5049
Dr. Gaglani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Pediatric Infectious Diseases, 1993 - 1996
University of MarylandResidency, Pediatrics, 1990 - 1993
Seth G.S. Medical CollegeClass of 1982
Certifications & Licensure
TX State Medical License 1996 - 2027
MD State Medical License 1995 - 1996
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Inaugural Josephine Ballard Endowed Research Chair BSWH and TEXAS A&M HSC COM
- Founder Director, Center for Research in Vaccines and Infections Baylor Scott & White Health
- Professor of Pediatrics Texas A&M University College of Medicine, 2011
Publications & Presentations
PubMed
- Influenza Antibody Levels Associated with Laboratory-Confirmed Influenza in a Test-Negative Study Design, US Flu VE Network, November 2018-May 2019.Brendan Flannery, Jessie R Chung, Crystal Holiday, Stacie Jefferson, Manjusha Gaglani
The Journal of Infectious Diseases. 2026-07-17 - Influenza vaccine effectiveness against outpatient acute respiratory illness with laboratory-confirmed influenza, United States, 2024-25 season.Jessie R Chung, Ashley M Price, Stacey L House, Jamie Mills, Karen J Wernli
Clinical Infectious Diseases. 2026-07-14 - Hemagglutination-inhibition and microneutralization antibody titers as mediators of protection for cell-based and recombinant influenza vaccines.Shuyi Zhong, Wey Wen Lim, Faith Ho, Manjusha Gaglani, Allison L Naleway
NPJ Vaccines. 2026-07-09
Journal Articles
- Influenza Vaccine Effectiveness in the United States During the 2016–2017 SeasonManjusha Gaglani, MD, Clinical Infectious Diseases
Press Mentions
- Will Kids Be up Next for the Pfizer Vaccine?September 20th, 2021
- Texas Vaccine Scientist Says COVID-19 Shots WorkJuly 1st, 2021
- How Effective Are COVID-19 Vaccines in the Real World? Two Studies Offer 'Stunning' Results, Doctor SaysMay 12th, 2021
Grant Support
- RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).BAYLOR RESEARCH INSTITUTE2022–2027
- RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).BAYLOR RESEARCH INSTITUTE2022–2027
- RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).BAYLOR RESEARCH INSTITUTE2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
